SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals rises on incorporating subsidiary in Philippines

23 Apr 2026 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 779.00, up by 14.80 points or 1.94% from its previous closing of Rs. 764.20 on the BSE.

The scrip opened at Rs. 765.00 and has touched a high and low of Rs. 779.00 and Rs. 763.95 respectively. So far 95 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1107.80 on 30-Jun-2025 and a 52 week low of Rs. 635.30 on 23-Mar-2026.

Last one week high and low of the scrip stood at Rs. 796.00 and Rs. 749.00 respectively. The current market cap of the company is Rs. 15151.09 crore.

The promoters holding in the company stood at 69.74%, while Institutions and Non-Institutions held 20.43% and 9.83% respectively.

Alembic Pharmaceuticals has incorporated a subsidiary named 'Alembic Lifesciences Philippines Inc.' in Philippines. The company has incorporated a subsidiary to explore new business opportunities in this geography to promote, sale and distribute pharmaceuticals product(s) of the company. The company holds 99.99% stake in Alembic Lifesciences Philippines Inc.

Alembic Pharmaceuticals is involved in manufacturing and marketing of India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities.

Alembic Pharma Share Price

751.10 -18.70 (-2.43%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×